If you are in all Kirk's companies, do you own SYN? Look like today's loss in SYN, one of his cos, totally offsets gains in ZIOP! May be the best way to invest in Kirk is to invest in ZON which will benefit from success of all these small and diversified cos, while individual failure won't affect much your investment. Of course I don't mean SYN will not succeed, rather it is one of the Kirk's cos with the biggest potential, IMO.
Actually to your question, I believe this boyish guy will settle for a chevy over a Benz, not because unwillingness to wait, but he just can't afford a high priced product. This is why these people play shorts which is like margin play without having to have real capital to really invest in the market. Arguing with these people is futile.
If stock market acts according to text, then everybody makes money and you know it is not so. QE3, as you are so worried about its ending which, the pundits say, will lead to a stock market crash! It is simply not that easy. The more people worry about the market, the better it will perform. Like what Buffett has said "be greedy when everybody is fearful and be fearful, when everybody is greedy". This is the very reason many hedge funds will fold because they tried to outsmart the market and gave dire predictions and shorted the market. Other than a few smart ones that also long the market, many short hedgies have lost billions. While keeping some cash as dry powder for opportunities is prudent, but to sell all your positions for fear of a market crash is a totally wrong way to invest. Just look at the few suggested stocks I mentioned yesterday, one has already jumped 10% today. Listen to me and act accordingly will make you money. All such suggestions come free as well! The reason for most investors to lose money is they listen too much of the WS pundits whose interest is with their own financial institutions and large clients.
These people are not even honest. When I said insiders' selling regularly and relentlessly, I meant those management from CEO to CFO etc. Only one senior manager hasn't participate in such so-called automatic selling with the price set at, I think, at $10! They have their secondary offering at $22 and immediately increase the share size, so that they will have enough to give management free option shares. Like you I have a large position and is under water. The management is paid well. The CEO's compensation is over 1 million and he sold I believe 8000 shares EVERY month! How much he needs for his life style? I won't even mind if there is something substantially developed for new drug application. So far none. If management is willing to sell regularly at $10, that means they collectively value the share price at that level. Small wonder SGMO has been struggling ever since the secondary offering despite the partnership with BIIB. One of my most disappointment biotech holdings.
I agree this is a speculative trade, like most of the stocks for those posting here.
I accept the fact there will be winners and losers. As long as one doesn't use margin and has no immediate need for the money, you can reap/harvest gains and wait for losers become winners. In a bull market like this one, despite the occasional scary dips which actually gave one opportunity to buy, one always has more gainers to offset a few losers. Go short in this environment is for trouble you don't need. DDD is a profitable company, unlike AMZN, so it will bounce back soon enough. They just couldn't push it down under $36, so the low is set. This will go back over $40 in a week. A piece of advice to shorts, try to go long and buy SYN and ZIOP which are cheap stocks fitting your appetite. You'll thank me in a month. For those of you with more resources, but FB, TWTR, GILD and FEYE..
With seemingly positive earnings report and plenty cash at hand, this stock can't break $12! This is really a broken stock and I attribite the failing to the insiders' selling of stock practically at any price. Look like most of the investors lost money but the management team make out good and can reload their free option shares and turn around and sell them. Disgusting. This is why we need activist fund managers to get in and force the management/board to be more shareholders friendly, not self-serving treating the co as their piggy bank.
"This entire market is going to crash soon". Really? Those hedge funds that had predicted the same merely a few weeks ago are big losers now with quite a few may go belly up by the end of the year. I am glad you are in that camp. I bought a lot stocks during the recent period of dire predictions and am happy to see how these stocks have worked out these days. DDD is a different story. It is still a profitable company so it should do okay longer term. On top of it, some companies, such as HPQ, may even boy it instead of developing its own 3 D capability. Longs may suffer now, but there is a lot to like at these low prices.
I like your interpretation of the data read. Hopefully you are on the mark. The share price has come down quite a bit despite the market turning up big time in the past few sessions. So it seems the market is not reading it as a positive. Another factor for the downward pressure may indicate anxiety on potentially another secondary offering as the co had to cut back on the size of the IPO without sufficient funds raised. With that hanging over the stock, it may not move up short time unless some positive news. I simply put it aside waiting for it to turn positive.
Most small biotech cos were killed. People putting money back to the market after the sell-off generally buy large established co, such as GILD or CELG. It will take a while for small ones being considered unless there is some potential immediate development. If you want those co, take a look at INO with its Ebola and MS play and SYN which is an infectious disease play as well as for other indications.
I believe the market is reacting to the PI data today on the 11 patients. It said 7 of the 11 patients left the trial due to disease progression. If that's the case, that meant the drug wasn't working too well, right? However the co also mentioned most with clinical activities from the drug. Not sure how to interpret it. This is a small co partnered with CELG, so may be there is something positive for the future. Don't forget this one came IPO not long ago and the small number of shares were picked up by insiders as well as CELG at $10. I'll simply stay put on this one. With such small float, any move, up or down, is exaggerated.
If this deal doesn't work out, SGPG will receive 1 billion dollars for break-up fee. Windfall money for the co. Additional, this take-over attempt put SHIG in play for other large pharmas. All in all, either way will be positive in my opinion.
The MB is quiet and stock continues to go down. Added some shares here. Other than its small float leading to less liquid trades, there is an over 5% dividend yield, a co buy back plan and its dominance in its niche gaming equipment sector. What not to like if you can keep these shares for a year or two to allow it to be noticed, while getting paid at 5% while waiting . Will do exactly that and check the price a couple years later. Dividend must be safe it the co even engages in buying back shares.
I also checked on Rima's holding on IMMR. The hedge fund has not either increased or decreased its shares on IMMR. In fact this IMMR position is their largest position in $$ terms. Wonder why it is not taking any action, unless it is doing so behind the scene. So far RIMA has a huge paper loss in this position. Well, I am sure I can use some positive news.
If this is a gravy train for the management, particularly the CEO, as you said, they will never want to sell the co to "kill the golden goose". So what we need is an activist fund with large stake in this stock..To my surprise, there is a very high number of institution ownership with over 80% owned by funds. Wonder if one or a couple of them decide to take some actions to push for shareholders' value. One fund actually owns 18% of shares and I wonder why they don't do something here. Let's hope for some changes.
Share price has steadily gone down since last earnings and has hit low multiple times including today. This is supposedly a profitable co with some niche technology as well as contract agreement signed recently. What's wrong?
With a confirmed case in Texas and another probable case in Boston just announced an hour ago, this Ebola problem is getting a bit out of hand if you consider each identified patient representing another 40 to be followed. I believe INO's proven effective vaccine for 100% animal immunity will be considered because the vaccine can be mass produced quickly. As a matter of fact, I am not sure why it is not used, at least for some patients, in West Africa since there is no known cure. We must do everything to stop this Ebola virus from spreading. This is a world-wide crisis..
I saw the CNBC program in talking about why FEYE's stock price is so low. The reason, as they mentioned, was NOT the selling of stock at the high by management but WITHOUT telling people. It implied ethical lapse on the part of those insiders, while it might be legal. Had I known of such practice, I would not have bought shares. No wonder it is at one third of its high while it primary competitor is at its high of the year. Shame on the management.
Please stop peddling that co headed by a snake oil salesman with an MBA! Check how he fooled investors last time around with his failed melanoma trial! Also this guy, along with the largest investor have been selling shares. No comparison with INO which has the best science and is led by a very competent and honest scientist and supported by a board with known academic and science accomplishments. Dr. Kim also put his money where his mouth is by buying 2 millions shares from the open market without selling one single share of his holding. That spells confidence to me.
I think you are part of the scam the Washington Post disclosed by this investigation reporter. You are probably simply one of the hired by hedgies to post here, so may get away with minimum jail sentence such as a few months. Your boss will be in real trouble.